These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 16897745)

  • 1. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
    Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
    Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
    Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
    Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.
    Barnes LM; Bentley CM; Moy N; Dickson AJ
    Biotechnol Bioeng; 2007 Feb; 96(2):337-48. PubMed ID: 17001634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a cholesterol-independent, non-GS NS0 cell line through chemical treatment and application for high titer antibody production.
    Li J; Gu W; Edmondson DG; Lu C; Vijayasankaran N; Figueroa B; Stevenson D; Ryll T; Li F
    Biotechnol Bioeng; 2012 Jul; 109(7):1685-92. PubMed ID: 22252532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS0 cell damage by high gas velocity sparging in protein-free and cholesterol-free cultures.
    Zhu Y; Cuenca JV; Zhou W; Varma A
    Biotechnol Bioeng; 2008 Nov; 101(4):751-60. PubMed ID: 18814288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
    Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
    Browne SM; Al-Rubeai M
    Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells.
    Barnes LM; Bentley CM; Dickson AJ
    Biotechnol Bioeng; 2004 Jan; 85(2):115-21. PubMed ID: 14704993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced productivity of NS0 cells in fed-batch culture with cholesterol nanoparticle supplementation.
    Wu Y; Ma N; Wyslouzil BE; Chalmers JJ; McCormick E; Casnocha SA
    Biotechnol Prog; 2011; 27(3):796-802. PubMed ID: 21509955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
    Frahm B; Lane P; Märkl H; Pörtner R
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
    Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
    Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol delivery to NS0 cells: challenges and solutions in disposable linear low-density polyethylene-based bioreactors.
    Okonkowski J; Balasubramanian U; Seamans C; Fries S; Zhang J; Salmon P; Robinson D; Chartrain M
    J Biosci Bioeng; 2007 Jan; 103(1):50-9. PubMed ID: 17298901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate.
    Dinnis DM; Stansfield SH; Schlatter S; Smales CM; Alete D; Birch JR; Racher AJ; Marshall CT; Nielsen LK; James DC
    Biotechnol Bioeng; 2006 Aug; 94(5):830-41. PubMed ID: 16489627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC.
    Kanda Y; Yamane-Ohnuki N; Sakai N; Yamano K; Nakano R; Inoue M; Misaka H; Iida S; Wakitani M; Konno Y; Yano K; Shitara K; Hosoi S; Satoh M
    Biotechnol Bioeng; 2006 Jul; 94(4):680-8. PubMed ID: 16609957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells.
    Schlatter S; Stansfield SH; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Prog; 2005; 21(1):122-33. PubMed ID: 15903249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hyperosmotic pressure on antibody production and gene expression in the GS-NS0 cell line.
    Wu MH; Dimopoulos G; Mantalaris A; Varley J
    Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):41-6. PubMed ID: 15270706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines.
    Khoo SH; Falciani F; Al-Rubeai M
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):85-95. PubMed ID: 17223793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.